Leo KY Chow

Leo KY Chow has a wealth of work experience, beginning with a Junior Research Assistant (Summer Work) at The Chinese University of Hong Kong in 2005. Leo KY then worked as Technology Liaison Officer at the same university from 2011 to 2015. In 2015, they became an Investment Associate, Life Science Investment at TVM Capital Life Science. In 2017, they moved to Bank of China Group Investment Limited as Senior Manager, Healthcare Investment. In 2018, they joined Prudential Corporation Asia as Senior Manager, Strategic Investment. Leo KY then moved to GF Securities in 2019 as Vice President, Healthcare Investment. Currently, they are Senior Director, Business Development at Reistone Biopharma.

Leo KY Chow obtained a PhD in Biomedical Science from the University of Nottingham in 2010, focusing on the Regulation of Transcription. Leo KY also holds a Biomolecular Science degree from King's College London in the field of Life Science.